• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Gastrointestinal Cancers: Progress with Targeted Therapies

  • — 27 Jan, 2008
AudioMedica News
AudioMedica News
Gastrointestinal Cancers: Progress with Targeted Therapies
Gastrointestinal Cancers: Progress with Targeted Therapies
00:00 /
RSS Feed
Share
Link
Embed
Robert Mayer
Robert Mayer

ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and pancreas cancers.

Gastrointestinal Cancers: Progress with Targeted Therapies



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080126_robert_mayer.mp3]

You may also like...

  • Professor Harry de Koning MD PhD Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per Cent 7 Feb, 2020
  • Adjuvant Checkpoint Inhibition Extends Disease-Free and Overall Survival in Patients with Stage III Melanoma Adjuvant Checkpoint Inhibition Extends Disease-Free and Overall Survival in Patients with Stage III Melanoma 13 Oct, 2016
  • John Gribben Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically 9 Aug, 2013
  • Jorge Cortes Chronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutation 18 Dec, 2012
  • Previous story Liver Cancer: Risk Groups for Screening
  • Next story Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • New Front Line Standard for Older Patients with Chronic…
  • Home
  • Oncology
  • Gastrointestinal Cancers: Progress with Targeted Therapies

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.